What is the market doing?
What the tape says about TSHA
Taysha Gene Therapies, Inc. is +114% over the past year while the S&P 500 is +23%: 91 points ahead of the market.
+114%
1-year return · S&P 500 +23%
- vs 200-day average
- +14%
vs 200-day average · a clear uptrend
- RSI (14)
- 44
RSI (14) · neutral
- Below its 52-week high
- −14%
Below its 52-week high
Details›
- Last close2026-08-26
- $6.01
- 1 monthS&P 500 +3.7%
- +2.9%
- 1 yearS&P 500 +23%
- +114%
- 5 yearsS&P 500 +87%
- −67%
- vs 50-day average$5.99
- +0.28%
- 52-week high
- $6.98
- 52-week low
- $2.72
- Annualised volatility
- 95%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$1.9M
| Year | Return |
|---|---|
| 2026 (year to date) | +9.3% |
| 2025 | +218% |
| 2024 | −2.3% |
| 2023 | −22% |
| 2022 | −81% |
| 2021 | −56% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 0 of 6 | −18% |
| Feb | 6 | 3 of 6 | +9.2% |
| Mar | 6 | 1 of 6 | −10% |
| Apr | 6 | 3 of 6 | +7.9% |
| May | 6 | 2 of 6 | +3.3% |
| Jun | 6 | 2 of 6 | −1.5% |
| Jul | 6 | 3 of 6 | −0.41% |
| Aug | 6 | 5 of 6 | +64% |
| Sep | 5 | 1 of 5 | −9.0% |
| Oct | 6 | 1 of 6 | −4.0% |
| Nov | 6 | 3 of 6 | +14% |
| Dec | 6 | 4 of 6 | −3.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.